Monthly Archives: November 2016

Clay Siegall Uses His Passion For Science To Help Cancer Patients

Clay Siegall is the co-founder and CEO of Seattle Genetics. He is a trained scientist who emphasizes on cancer therapies. Dr. Siegall created Seattle Genetics in 1998, in Bothell, Washington. Seattle Genetics was created with Dr. Siegall’s passion for helping patients through rigorous research and drug development practices.

1.Siegall has led the company to its current position as a leader in developing antibody-drug conjugates, or ADCs. In 2011, the FDA approved its first ADC product. Adcetris is now a global drug approved in more than 60 countries. In addition to Adcetris, Seattle Genetics is evolving a pipeline of ADCs for treating cancer.

Adcetris is Seattle Genetics’ lead program which is produced in collaboration with Takeda Pharmaceutical Company Limited. They are currently participating in a clinical development program to evaluate its potential to become the main form of treatment for treating advanced forms of cancer.

Their ADCs are created using Clay Siegall’s patented technology and includes more than 12 clinical programs. Their ADC technology is used by collaborators to work towards empowering antibodies to help improve treatment outcomes for cancer patients.

Under Siegall’s leadership, the drug company has entered into many licenses for its technology that have created more than $325 million. Across many programs, there are now more than 20 ADCs in development using Dr. Siegall’s technology. He has secured more than $1.2 billion in financing, which includes the company’s public offering in 2001.

Before founding Seattle Genetics, Clay Siegall worked for the Bristol-Myers Pharmaceutical Research Institute until 1997. Prior to that, he worked for both the National Cancer Institute and the National Institutes of Health until 1991.

2.Siegall currently serves on the Board of Directors at Mirna Therapeutics, Washington Roundtable, Ultragenyx Pharmaceutical, and Alder BioPharmaceuticals. He has received many awards, one of which was the 2012 Pacific Northwest Ernst & Young Entrepreneur of the Year.

In addition to his many work-related accomplishments, Clay Siegall has writted over 70 publications and currently holds 15 patents. His education includes a Bachelor’s Degree in Zoology from the University of Maryland and a Ph.D. in Genetics from the George Washington University.

EOS Lip Balm is on the Lips of Millennial Women

Inspired entrepreneurs saw the world of lip care in a slicker way than the traditional lip balms on the market. EOS (Evolution of Smooth) Lip Balm, the creation of co-founders Sanjiv Mehra and Jonathan Teller, is now the second most popular lip balm on the market.

Focus, Focus, Focus

Lip Balm was originally thought of as a practical, faintly medicinal, and totally unisex product. But focus groups showed a different trend. Women were the vast majority of consumers. Young women were ready for something that spoke to them. They knew what they wanted, and what they wanted was organic. Literally.

A Sense of Delight

With this new knowledge of the consumer base, EOS Lip Balm created a product that appealed to women. They desired an experience that delighted the senses. From the happy little click that closes the soft round plastic container to the pastel colors and fun flavors that enliven the senses, a part of daily personal care became an opportunity for a moment of pleasure. The EOS motto is “The lip balm that makes you smile.”

It Takes One Fan

A hurdle to overcome was product placement. Many buyers were men who didn’t understand EOS Lip Balm. But one female buyer from Walgreens was a fan and the lip balm gained traction.

Gliding Across the Lips of Celebrities

In the age of instant communication, social media stars such as Christina Aguilera, Miley Cyrus, and Taylor Swift took a shine to EOS Lip Balm; beauty bloggers sang its praise with moist lips on Instagram, Facebook, YouTube and Linked In ( . Millennial women listened. Fortunately, with its own production facilities, the company was able to keep up with the ballooning pace of demand.

The Future Looks Good

EOS Lip Balm currently sells 1 million units a week on ULTA. With predictions of global lip care to increase to 2 billion by 2020, the future is worth smiling about.

Plans for EOS, which already introduced a sports shoe to coordinate with a flavored lip balm, include new lines of products and cross-marketing platforms.

The Evolution of Smooth continues to evolve. For more information, visit the  website: